FDA neurology regulator Bastings joins Ionis

After a 21-year career regulating neurology drugs at FDA, Eric Bastings has accepted a position as VP for development strategy at Ionis, which has a dozen neurology antisense programs in clinical testing.

Ionis Pharmaceuticals Inc. (NASDAQ:IONS) also hired Joseph Baroldi as EVP and CBO...